Cover Image
市場調查報告書

生物銀行的全球市場:2016∼2020年

Global Biobanking Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 248654
出版日期 內容資訊 英文 145 Pages
訂單完成後即時交付
價格
Back to Top
生物銀行的全球市場:2016∼2020年 Global Biobanking Market 2016-2020
出版日期: 2015年11月18日 內容資訊: 英文 145 Pages
簡介

全球生物銀行市場預計到2020年以年複合成長率8%踏實成長。在各地區中,一般認為EMEA到2020年持有約44%的佔有率。瑞典、挪威、丹麥、芬蘭、冰島等北歐各國中存在充分確立的生物銀行系統成為推動該地區市場擴大的一大要素。

本報告提供全球生物銀行市場相關調查、該市場的現狀與至2020年的成長前景、各產品/各樣品趨勢/各地區市場佔有率、主要供應商概要、市場課題與趨勢等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 生物銀行:概要

  • 生物銀行的種類
  • 生物銀行的分類
  • 商業性生物銀行清單

第6章 樣品保管條件

  • 室溫管理
  • 冷藏
  • 冷凍
  • 超低溫
  • 極低溫LN2

第7章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第8章 生物銀行的資金和財務永續性

  • 費用回收模式的動機

第9章 生物銀行的調整

第10章 各產品市場區隔

  • 市場概要

第11章 各樣品市場區隔

  • 局部
  • 口服

第12章 各地區市場區隔

  • 歐洲、中東、非洲
  • 南北美洲
  • 亞太地區

第13章 推動市場的要素

  • 高齡化和慢性疾病的發病率上升
  • 自動化造成的效率化
  • 研究成本的削減

第14章 促進要素的影響

第15章 市場課題

第16章 促進要素與課題的影響

第17章 市場趨勢

第18章 供應商環境

  • 競爭模式
  • 市場佔有率分析
  • Beckman Coulter
  • BioCision
  • Taylor-Wharton
  • Tecan Group
  • Thermo Fisher Scientific
  • VWR
  • 其他值得注意的供應商

第19章 附錄

第20章 關於Technavio

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR7852

Covering: This market research report includes a detailed segmentation of the global biobanking market by product type (equipment and consumables) and by sample type (human tissues, stem cells, DNA or RNA, bio-fluids, and others). It also outlines the market shares for key regions such as the Americas, APAC, and EMEA. The key vendors analyzed in this report are Beckman Coulter, BioCision, Taylor-Wharton, Tecan, Thermo Fisher, and VWR.

Market outlook of the global biobanking market

Technavios market research analyst predicts the global biobanking market to grow steadily at a CAGR of approximately 8% during the forecast period. The ability of biobanks to aid in the collection, preparation, processing, handling, recovery, storage, and distribution of tissues and cell samples for therapeutic and research purposes are expected to result in this markets impressive growth rate during the forecast period.

Geographically, the EMEA region is estimated to account for a market share of approximately 44% during the predicted period. The presence of a well-established biobanking system in the Nordic countries, such as Sweden, Norway, Denmark, Finland, and Iceland, is a significant factor that bolsters market growth in this region during the forecast period.

Segmentation by sample type and analysis of the biobanking market

  • Human tissues
  • Stem cells
  • DNA or RNA
  • Bio-fluids
  • Others

According to this market research, the human tissues segment is estimated to account for a market share of approximately 65% during the forecast period. The unavailability of appropriate animal models for some neurological and psychiatric disorders is a critical factor that results in the growing preference for human tissue specimens or samples stored in biobanks.

Product-type segmentation of the biobanking market

  • Equipment
  • Consumables

Technavio market research analysts have predicted the equipment segment to be the largest market segment during the forecast period. The ability of this segment to aid in the storage, handling, maintenance, transport, and tracking of samples and specimens is a noteworthy factor, which results in its impressive market share of more than 74% during the estimated period.

Competitive landscape and key vendors

This market is highly fragmented due to the presence of numerous small and large vendors and is primarily dominated by prominent vendors like Beckman Coulter and Taylor-Wharton. Since the products offered in this market are similar in nature, vendors have to differentiate their services in terms of automation of existing technology and value-added services to gain an edge over their rivals.

The top vendors in this market are -

  • Beckman Coulter
  • BioCision
  • Taylor-Wharton
  • Tecan Group
  • Thermo Fisher Scientific
  • VWR

Other prominent vendors analyzed in this market study are Askion, B&C Group, BioBank, BioCryo, BioRep, BioStorage Technologies, Bluechip, Brooks Life Science Systems, Cryo Bio System, CryoXtract, DNA Genotek, Excilone, Fluidx, Indivumed, LVL Technologies, Micronic, Promega, QIAGEN, RURO, Seralab, SOL Group, Tissue Solutions, Trans-Hit Biomarkers, and Wildcat Laboratory Solutions.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020
  • What are the key factors driving the global biobanking market
  • What are the key market trends impacting the growth of the global biobanking market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the vendors in the global biobanking market
  • What are the trending factors influencing the market shares of the Americas, APAC, and EMEA
  • What are the key outcomes of the five forces analysis of the biobanking market

Technavio also offers customization on reports based on specific client requirement.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Biobanks: An overview

  • Types of biobanks
  • Classification of biobanks
  • List of commercial biobanks

PART 06: Storage conditions for samples

  • Controlled room temperature
  • Refrigeration
  • Frozen
  • Ultra-low
  • Cryogenic LN2

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Biobank funding and financial sustainability

  • Moving toward cost recovery model

PART 09: Harmonization of biobanking

PART 10: Market segmentation by product

  • Market overview
  • Global biobanking equipment market
  • Global biobanking consumables market

PART 11: Market segmentation by sample type

  • Market overview

PART 12: Geographical segmentation

  • Biobanking market in EMEA
  • Biobanking market in Americas
  • Biobanking market in APAC

PART 13: Market drivers

  • Rise in aging population and incidence of chronic diseases
  • Increase in efficiency through automation
  • Reduction in research costs

PART 14: Impact of drivers

PART 15: Market challenges

PART 16: Impact of drivers and challenges

PART 17: Market trends

PART 18: Vendor landscape

  • Competitive scenario
  • Market share analysis
  • Beckman Coulter
  • BioCision
  • Taylor-Wharton
  • Tecan Group
  • Thermo Fisher Scientific
  • VWR
  • Other prominent vendors

PART 19: Appendix

  • List of abbreviations

PART 20: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Workflow of a typical biobank
  • Exhibit 03: Topology of biobanks
  • Exhibit 04: Storage temperature preference for various samples in biobanks (%)
  • Exhibit 05: Global biobanking market 2015-2020 ($ billions)
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Organizations and their initiatives for biobank harmonization
  • Exhibit 08: Key factors involved in harmonization of biobanks
  • Exhibit 09: Key focus areas in harmonization of biobanks
  • Exhibit 10: Organizations and initiatives in harmonizing science and infrastructure
  • Exhibit 11: Initiatives in biobanking resource tools and databases
  • Exhibit 12: Global biobanking market segmentation by product type
  • Exhibit 13: Segmentation of global biobanking market by product type, 2015
  • Exhibit 14: Global biobanking equipment market ($ billions)
  • Exhibit 15: Global biobanking equipment market segmentation by product 2015
  • Exhibit 16: Global automation equipment market 2015-2020 ($ billions)
  • Exhibit 17: Global biobanking non-automation equipment market ($ billions)
  • Exhibit 18: Global biobanking consumables market 2015-2020 ($ billions)
  • Exhibit 19: Global biobanking market by type
  • Exhibit 20: Global biobanking market segmentation by sample type 2014
  • Exhibit 21: Global biobanking market segmentation by region 2015
  • Exhibit 22: Biobanking market in EMEA 2015-2020 ($ billions)
  • Exhibit 23: List of biobanks in EMEA
  • Exhibit 24: Biobanking market in Americas 2015-2020 ($ billions)
  • Exhibit 25: List of biobanks in Americas
  • Exhibit 26: Biobanking market in APAC 2015-2020 ($ millions)
  • Exhibit 27: List of biobanks in APAC
  • Exhibit 28: Impact of drivers
  • Exhibit 29: Impact of drivers and challenges
  • Exhibit 30: Beckman Coulter: Key takeaways
  • Exhibit 31: Beckman Coulter: Business segmentation
  • Exhibit 32: BioCision: Key takeaways
  • Exhibit 33: BioCision: Business segmentation
  • Exhibit 34: BioCision: Biobanking solutions
  • Exhibit 35: Taylor-Wharton: Key takeaways
  • Exhibit 36: Taylor-Wharton: Business segmentation
  • Exhibit 37: Tecan: Key takeaways
  • Exhibit 38: Tecan Group: Business segmentation by revenue 2014
  • Exhibit 39: Tecan Group: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 40: Tecan Group: Geographical segmentation by revenue 2014
  • Exhibit 41: Tecan Group: Geographical segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 42: Thermo Fisher Scientific: Key takeaways
  • Exhibit 43: Thermo Fisher Scientific: Business segmentation by revenue 2014
  • Exhibit 44: Thermo Fisher Scientific: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 45: Thermo Fisher Scientific: Geographical segmentation by revenue 2014
  • Exhibit 46: VWR: Key takeaways
  • Exhibit 47: VWR: Products and service segmentation by revenue 2014
  • Exhibit 48: VWR: Market segmentation by revenue 2014
  • Exhibit 49: VWR: Geographical segmentation by revenue 2014
  • Exhibit 50: VWR: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 51: VWR: Geographical segmentation by revenue 2014
Back to Top